Atlas Trials

Randomized Trial of G-CSF Alone Versus Intermediate-dose Ara-C Plus G-CSF Mobilization in Multiple Myeloma Patients.

Clinical trial NCT01908621 · COMPLETED

Trial details

NCT number
NCT01908621
Sponsor
Maria Sklodowska-Curie National Research Institute of Oncology
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Multiple Myeloma
Start date
2013-03-20
Primary completion
2016-03-18
Enrollment
90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.